Longitudinal study of DNA methylation of inflammatory genes and cancer risk

Cancer Epidemiology Biomarkers and Prevention

Volumn 24, Issue 10, 2015, Pages 1531-1538

  Joyce, Brian Thomas ^a,b   Gao, Tao ^a   Liu, Lei ^a   Zheng, Yinan ^a   Liu, Siran ^c   Zhang, Wei ^a   Penedo, Frank ^a   Dai, Qi ^d   Schwartz, Joel ^e   Baccarelli, Andrea A ^e   Hou, Lifang ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c Northwestern University   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERFERON; INTERLEUKIN 6; TOLL LIKE RECEPTOR 2; DNA; TUMOR MARKER;

AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKOCYTE; LONGITUDINAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; PROSTATE CANCER; ADULT; CARCINOGENESIS; DISEASE FREE SURVIVAL; FORECASTING; GENETICS; INCIDENCE; INFLAMMATION; METABOLISM; MIDDLE AGED; NEOPLASMS; PROMOTER REGION; PROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; TRENDS; UNITED STATES; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; CARCINOGENESIS; DISEASE-FREE SURVIVAL; DNA METHYLATION; DNA, NEOPLASM; FORECASTING; HUMANS; INCIDENCE; INFLAMMATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEOPLASMS; PROMOTER REGIONS, GENETIC; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; UNITED STATES; YOUNG ADULT;

EID: 84942869565     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-15-0198     Document Type: Article

References (58)

1. Hussain SP, Harris CC. Inflammation and cancer: An ancient link with novel potentials. Int J Cancer 2007;121:2373-80.
2. Xu B, Niu XB, Wang ZD, Cheng W, Tong N, Mi YY, et al. IL-6 -174G>C polymorphism and cancer risk: A meta-analysis involving 29, 377 cases and 37, 739 controls. Mol Biol Rep 2011;38:2589-96.
3. Borges AH, Silverberg MJ, Wentworth D, Grulich AE, Fatkenheuer G, Mitsuyasu R, et al. Predicting risk of cancer during HIV infection: The role of inflammatory and coagulation biomarkers. Aids 2013;27:1433-41.
4. Zhang FF, Santella RM, Wolff M, Kappil MA, Markowitz SB, Morabia A. White blood cell global methylation and IL-6 promoter methylation in association with diet and lifestyle risk factors in a cancer-free population. Epigenetics 2012;7:606-14.
5. Murata M, Thanan R, Ma N, Kawanishi S. Role of nitrative and oxidative DNA damage in inflammation-related carcinogenesis. J Biomed Biotechnol 2012;2012:623019.
6. Bayarsaihan D. Epigenetic mechanisms in inflammation. J Dent Res 2011;90:9-17.
7. McAllister F, Bailey JM, Alsina J, Nirschl CJ, Sharma R, Fan H, et al. Oncogenic Kras activates a hematopoietic-to-epithelial IL-17 signaling axis in preinvasive pancreatic neoplasia. Cancer Cell 2014;25:621-37.
8. Oberyszyn TM, Conti CJ, Ross MS, Oberyszyn AS, Tober KL, Rackoff AI, et al. Beta2 integrin/ICAM-1 adhesion molecule interactions in cutaneous inflammation and tumor promotion. Carcinogenesis 1998;19:445-55.
9. Yongvanit P, Thanan R, Pinlaor S, Sithithaworn P, Loilome W, Namwat N, et al. Increased expression of TLR-2, COX-2, and SOD-2 genes in the peripheral blood leukocytes of opisthorchiasis patients induced by Opisthorchis viverrini antigen. Parasitol Res 2012;110:1969-77.
10. Abu-Remaileh M, Bender S, Raddatz G, Ansari I, Cohen D, Gutekunst J, et al. Chronic inflammation induces a novel epigenetic program that is conserved in intestinal adenomas and in colorectal cancer. Cancer Res 2015;75:2120-30.
11. Hahn MA, Hahn T, Lee DH, Esworthy RS, Kim BW, Riggs AD, et al. Methylation of polycomb target genes in intestinal cancer is mediated by inflammation. Cancer Res 2008;68:10280-9.
12. Ueda Y, Ando T, Nanjo S, Ushijima T, Sugiyama T. DNA methylation of microRNA-124a is a potential risk marker of colitis-associated cancer in patients with ulcerative colitis. Dig Dis Sci 2014;59:2444-51.
13. Sowers JL, Johnson KM, Conrad C, Patterson JT, Sowers LC. The role of inflammation in brain cancer. Adv Exp Med Biol 2014;816:75-105.
14. Nelson WG, De Marzo AM, DeWeese TL, Isaacs WB. The role of inflammation in the pathogenesis of prostate cancer. J Urol 2004;172:S6-11; discussion S-2.
15. Song LN, Silva J, Koller A, Rosenthal A, Chen EI, Gelmann EP. The Tumor Suppressor NKX3.1 is Targeted for Degradation by DYRK1B Kinase. Mol Cancer Res 2015;13:913-22.
16. Yasmin R, Siraj S, Hassan A, Khan AR, Abbasi R, Ahmad N. Epigenetic regulation of inflammatory cytokines and associated genes in human malignancies. Mediators Inflamm 2015;2015:201703.
17. Ianni M, Porcellini E, Carbone I, Potenzoni M, Pieri AM, Pastizzaro CD, et al. Genetic factors regulating inflammation and DNA methylation associated with prostate cancer. Prostate Cancer Prostatic Dis 2013;16: 56-61.
18. Stoccoro A, KarlssonHL, Coppede F, Migliore L. Epigenetic effects of nanosized materials. Toxicology 2013;313:3-14.
19. Jimenez-Garza O, Baccarelli A, Byun HM, BattistaBartolucci G, Carrieri M. Gene-specific DNA methylation as a valuable tool for risk assessment: The case of occupational exposure to different VOC's in Mexican workers. Occup Environ Med 2014;71 Suppl1:A36.
20. Bollati V, Baccarelli A, Hou L, Bonzini M, Fustinoni S, Cavallo D, et al. Changes in DNA methylation patterns in subjects exposed to low-dose benzene. Cancer Res 2007;67:876-80.
21. Hou L, Zhang X, Tarantini L, Nordio F, Bonzini M, Angelici L, et al. Ambient PM exposure and DNA methylation in tumor suppressor genes: A crosssectional study. Part Fibre Toxicol 2011;8:25.
22. Dubois RN. Role of inflammation and inflammatory mediators in colorectal cancer. Trans Am Clin Climatol Assoc 2014;125:358-72; discussion 372-3.
23. Patel SA, Bhambra U, Charalambous MP, David RM, Edwards RJ, Lightfoot T, et al. Interleukin-6 mediated upregulation of CYP1B1 and CYP2E1 in colorectal cancer involves DNA methylation, miR27b and STAT3. Br J Cancer 2014;111:2287-96.
24. Song TY, Lim J, Kim B, Han JW, Youn HD, Cho EJ. The role of tumor suppressor menin in IL-6 regulation in mouse islet tumor cells. Biochem Biophys Res Commun 2014;451:308-13.
25. Wilson AG. Epigenetic regulation of gene expression in the inflammatory response and relevance to common diseases. J Periodontol 2008; 79:1514-9.
26. Backdahl L, Bushell A, Beck S. Inflammatory signalling as mediator of epigenetic modulation in tissue-specific chronic inflammation. Int J Biochem Cell Biol 2009;41:176-84.
27. Campion J, Milagro FI, Goyenechea E, Martinez JA. TNF-alpha promoter methylation as a predictive biomarker for weight-loss response. Obesity (Silver Spring) 2009;17:1293-7.
28. Nile CJ, Read RC, Akil M, Duff GW, Wilson AG. Methylation status of a single CpG site in the IL6 promoter is related to IL6 messenger RNA levels and rheumatoid arthritis. Arthritis Rheum 2008;58:2686-93.
29. Richardson BC. Role of DNAmethylation in the regulation of cell function: Autoimmunity, aging and cancer. J Nutr 2002;132:2401s-5s.
30. Franco R, Schoneveld O, Georgakilas AG, Panayiotidis MI.Oxidative stress, DNA methylation and carcinogenesis. Cancer Lett 2008;266:6-11.
31. Hou L, Zhang X, Gawron AJ, Liu J. Surrogate tissue telomere length and cancer risk: shorter or longer? Cancer letters 2012;319:130-5.
32. Terry MB, Delgado-Cruzata L, Vin-Raviv N, Wu HC, Santella RM. DNA methylation in white blood cells: Association with risk factors in epidemiologic studies. Epigenetics 2011;6:828-37.
33. Madrigano J, Baccarelli A, Mittleman MA, Sparrow D, Vokonas PS, Tarantini L, et al. Aging and epigenetics: longitudinal changes in gene-specific DNA methylation. Epigenetics 2012;7:63-70.
34. Lepeule J, Baccarelli A, Motta V, Cantone L, Litonjua A, Sparrow D, et al. Gene promoter methylation is associated with lung function in the elderly: The Normative Aging Study. Epigenetics 2012;7:261-9.
35. Zhu ZZ, Sparrow D, Hou L, Tarantini L, Bollati V, Litonjua AA, et al. Repetitive element hypomethylation in blood leukocyte DNA and cancer incidence, prevalence, and mortality in elderly individuals: The Normative Aging Study. Cancer Causes Control 2011;22:437-47.
36. Cohen O, Kimchi A. DAP-kinase: from functional gene cloning to establishment of its role in apoptosis and cancer.Cell Death Differ 2001;8:6-15.
37. McGough JM, Yang D, Huang S, Georgi D, Hewitt SM, Rocken C, et al.DNA methylation represses IFN-gamma-induced and signal transducer and activator of transcription 1-mediated IFN regulatory factor 8 activation in colon carcinoma cells. Mol Cancer Res 2008;6:1841-51.
38. Lee KY, Geng H, Ng KM, Yu J, van Hasselt A, Cao Y, et al. Epigenetic disruption of interferon-gamma response through silencing the tumor suppressor interferon regulatory factor 8 in nasopharyngeal, esophageal and multiple other carcinomas. Oncogene 2008;27:5267-76.
39. Janson PC, Marits P, Thorn M, Ohlsson R, Winqvist O. CpG methylation of the IFNG gene as a mechanismto induce immunosuppression [correction of immunosupression] in tumor-infiltrating lymphocytes. J Immunol 2008;181:2878-86.
40. Lugade AA, Bogner PN, Thatcher TH, Sime PJ, Phipps RP, Thanavala Y. Cigarette smoke exposure exacerbates lung inflammation and compromises immunity to bacterial infection. J Immunol 2014;192:5226-35.
41. Ouyang B, Bernstein DI, Lummus ZL, Ying J, Boulet LP, Cartier A, et al. Interferon-gamma promoter is hypermethylated in blood DNA from workers with confirmed diisocyanate asthma. Toxicol Sci 2013;133: 218-24.
42. Ganapathi SK, Beggs AD, Hodgson SV, Kumar D. Expression and DNA methylation of TNF, IFNG and FOXP3 in colorectal cancer and their prognostic significance. Br J Cancer 2014;111:1581-9.
43. Ma D, Jiang C, Hu X, Li Q, Li T, Yang Y, et al. Methylation patterns of the IFN-gamma gene in cervical cancer tissues. Sci Rep 2014;4:6331.
44. Wee ZN, Li Z, Lee PL, Lee ST, Lim YP, Yu Q. EZH2-mediated inactivation of IFN-gamma-JAK-STAT1 signaling is an effective therapeutic target in MYCdriven prostate cancer. Cell Rep 2014;8:204-16.
45. Hellebrekers DM, Castermans K, Vire E, Dings RP, Hoebers NT, Mayo KH, et al. Epigenetic regulation of tumor endothelial cell anergy: silencing of intercellular adhesion molecule-1 by histone modifications. Cancer Res 2006;66:10770-7.
46. Arnold JM, Cummings M, Purdie D, Chenevix-Trench G. Reduced expression of intercellular adhesion molecule-1 in ovarian adenocarcinomas. Br J Cancer 2001;85:1351-8.
47. Pergoli L, Favero C, Pfeiffer RM, Tarantini L, Calista D, Cavalleri T, et al. Blood DNA methylation, nevi number, and the risk of melanoma. Melanoma Res 2014;24:480-7.
48. Chen H, Kazemier HG, de Groote ML, Ruiters MH, Xu GL, Rots MG. Induced DNA demethylation by targeting Ten-Eleven Translocation 2 to the human ICAM-1 promoter. Nucleic Acids Res 2014;42:1563-74.
49. Coral S, Parisi G, Nicolay HJ, Colizzi F, Danielli R, Fratta E, et al. Immunomodulatory activity of SGI-110, a 5-aza-20-deoxycytidine-containing demethylating dinucleotide. Cancer Immunol Immunother 2013;62: 605-14.
50. Friedrich MG, Chandrasoma S, Siegmund KD, Weisenberger DJ, Cheng JC, Toma MI, et al. Prognostic relevance of methylation markers in patients with non-muscle invasive bladder carcinoma. Eur J Cancer 2005;41:2769-78.
51. Zhang X, Wallace AD, Du P, Lin S, Baccarelli AA, Jiang H, et al. Genomewide study of DNA methylation alterations in response to diazinon exposure in vitro. Environ Toxicol Pharmacol 2012;34:959-68.
52. Giri D, Ozen M, Ittmann M. Interleukin-6 is an autocrine growth factor in human prostate cancer. Am J Pathol 2001;159:2159-65.
53. Hobisch A, Eder IE, Putz T, Horninger W, Bartsch G, Klocker H, et al. Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor. Cancer Res 1998;58:4640-5.
54. Calarco A, Pinto F, Pierconti F, Sacco E, Marrucci E, Totaro A, et al. Role of SOCS3 evaluated by immunohistochemical analysis in a cohort of patients affected by prostate cancer: preliminary results. Urologia 2012;79 Suppl19:4-8.
55. Pierconti F, Martini M, Pinto F, Cenci T, Capodimonti S, Calarco A, et al. Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior. Prostate 2011;71:318-25.
56. Sommer U, Schmid C, Sobota RM, Lehmann U, Stevenson NJ, Johnston JA, et al. Mechanisms of SOCS3 phosphorylation upon interleukin-6 stimulation. Contributions of Src- And receptor-tyrosine kinases. J Biol Chem 2005;280:31478-88.
57. Mordukhovich I, Reiter PL, Backes DM, Family L, McCullough LE, O'Brien KM, et al. A review of African American-white differences in risk factors for cancer: prostate cancer. Cancer Causes Control 2011;22: 341-57.
58. Graham-Steed T, Uchio E, Wells CK, Aslan M, Ko J, Concato J. 'Race' and prostate cancer mortality in equal-access healthcare systems. Am J Med 2013;126:1084-8.